Loading…
Cospray Dried Antibiotics for Dry Powder Lung Delivery
The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributi...
Saved in:
Published in: | Journal of pharmaceutical sciences 2008-08, Vol.97 (8), p.3356-3366 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053 |
---|---|
cites | cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053 |
container_end_page | 3366 |
container_issue | 8 |
container_start_page | 3356 |
container_title | Journal of pharmaceutical sciences |
container_volume | 97 |
creator | Adi, Handoko Young, Paul M. Chan, Hak-Kim Stewart, Peter Agus, Helen Traini, Daniela |
description | The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route. |
doi_str_mv | 10.1002/jps.21239 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69358508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916326375</els_id><sourcerecordid>69358508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</originalsourceid><addsrcrecordid>eNp10E1P2zAYB3BrAo3S7cAXQLkMiUOKHdtxfISWFlC1VXvRjpZrP5nM0qTYaUu-PYZ0cBknS_bvefEfoROCRwTj7OJ-HUYZyaj8gAaEZzjNMREHaBDfspRyJo_QcQj3GOMcc_4RHREhJaaYD1A-bsLa6y6ZeAc2uaxbt3RN60xIysbH2y5ZNDsLPplv6j_JBCq3Bd99QoelrgJ83p9D9Gt6_XN8k86_zW7Hl_PUMMplmhtJdckKxgAkg1ywJZWMFWA5J6bg0hQ5IVxwJorSFlIyQYwsgVhm-RJzOkRnfd-1bx42EFq1csFAVekamk1QuaS84LiI8LyHxjcheCjV2ruV9p0iWD2HpGJI6iWkaE_3TTfLFdg3uU8lgi97oIPRVel1bVx4dRmO-xJBo7vo3c5V0L0_Ud0tfvwbnfYVLrTw-Fqh_V-VCyq4-v119lw8_06upmoSPe09xJC3DrwKxkFtwDoPplW2cf_54BNdwJvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69358508</pqid></control><display><type>article</type><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><source>ScienceDirect (Online service)</source><source>Wiley Online Library All Journals</source><creator>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</creator><creatorcontrib>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</creatorcontrib><description>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.21239</identifier><identifier>PMID: 17990305</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Administration, Inhalation ; Aerosols ; Anti-Bacterial Agents - administration & dosage ; antibiotics ; Biological and medical sciences ; Ciprofloxacin - administration & dosage ; ciprofloxacin hydrochloride ; cospray drying ; Doxycycline - administration & dosage ; doxycycline hydrochloride ; DPI ; Drug Combinations ; dry powder inhaler ; General pharmacology ; Humans ; Lung - metabolism ; Medical sciences ; Microbial Sensitivity Tests ; Microscopy, Electron, Scanning ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Powders ; Pseudomonas aeruginosa - drug effects ; Staphylococcus aureus - drug effects ; Streptococcus pyogenes - drug effects ; X-Ray Diffraction</subject><ispartof>Journal of pharmaceutical sciences, 2008-08, Vol.97 (8), p.3356-3366</ispartof><rights>2008 Wiley‐Liss, Inc.</rights><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</citedby><cites>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.21239$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354916326375$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20547173$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17990305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adi, Handoko</creatorcontrib><creatorcontrib>Young, Paul M.</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><creatorcontrib>Stewart, Peter</creatorcontrib><creatorcontrib>Agus, Helen</creatorcontrib><creatorcontrib>Traini, Daniela</creatorcontrib><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</description><subject>Administration, Inhalation</subject><subject>Aerosols</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>antibiotics</subject><subject>Biological and medical sciences</subject><subject>Ciprofloxacin - administration & dosage</subject><subject>ciprofloxacin hydrochloride</subject><subject>cospray drying</subject><subject>Doxycycline - administration & dosage</subject><subject>doxycycline hydrochloride</subject><subject>DPI</subject><subject>Drug Combinations</subject><subject>dry powder inhaler</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lung - metabolism</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microscopy, Electron, Scanning</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Powders</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Streptococcus pyogenes - drug effects</subject><subject>X-Ray Diffraction</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp10E1P2zAYB3BrAo3S7cAXQLkMiUOKHdtxfISWFlC1VXvRjpZrP5nM0qTYaUu-PYZ0cBknS_bvefEfoROCRwTj7OJ-HUYZyaj8gAaEZzjNMREHaBDfspRyJo_QcQj3GOMcc_4RHREhJaaYD1A-bsLa6y6ZeAc2uaxbt3RN60xIysbH2y5ZNDsLPplv6j_JBCq3Bd99QoelrgJ83p9D9Gt6_XN8k86_zW7Hl_PUMMplmhtJdckKxgAkg1ywJZWMFWA5J6bg0hQ5IVxwJorSFlIyQYwsgVhm-RJzOkRnfd-1bx42EFq1csFAVekamk1QuaS84LiI8LyHxjcheCjV2ruV9p0iWD2HpGJI6iWkaE_3TTfLFdg3uU8lgi97oIPRVel1bVx4dRmO-xJBo7vo3c5V0L0_Ud0tfvwbnfYVLrTw-Fqh_V-VCyq4-v119lw8_06upmoSPe09xJC3DrwKxkFtwDoPplW2cf_54BNdwJvc</recordid><startdate>200808</startdate><enddate>200808</enddate><creator>Adi, Handoko</creator><creator>Young, Paul M.</creator><creator>Chan, Hak-Kim</creator><creator>Stewart, Peter</creator><creator>Agus, Helen</creator><creator>Traini, Daniela</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200808</creationdate><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><author>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Inhalation</topic><topic>Aerosols</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>antibiotics</topic><topic>Biological and medical sciences</topic><topic>Ciprofloxacin - administration & dosage</topic><topic>ciprofloxacin hydrochloride</topic><topic>cospray drying</topic><topic>Doxycycline - administration & dosage</topic><topic>doxycycline hydrochloride</topic><topic>DPI</topic><topic>Drug Combinations</topic><topic>dry powder inhaler</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lung - metabolism</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microscopy, Electron, Scanning</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Powders</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Streptococcus pyogenes - drug effects</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adi, Handoko</creatorcontrib><creatorcontrib>Young, Paul M.</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><creatorcontrib>Stewart, Peter</creatorcontrib><creatorcontrib>Agus, Helen</creatorcontrib><creatorcontrib>Traini, Daniela</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adi, Handoko</au><au>Young, Paul M.</au><au>Chan, Hak-Kim</au><au>Stewart, Peter</au><au>Agus, Helen</au><au>Traini, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cospray Dried Antibiotics for Dry Powder Lung Delivery</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2008-08</date><risdate>2008</risdate><volume>97</volume><issue>8</issue><spage>3356</spage><epage>3366</epage><pages>3356-3366</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>17990305</pmid><doi>10.1002/jps.21239</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2008-08, Vol.97 (8), p.3356-3366 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_69358508 |
source | ScienceDirect (Online service); Wiley Online Library All Journals |
subjects | Administration, Inhalation Aerosols Anti-Bacterial Agents - administration & dosage antibiotics Biological and medical sciences Ciprofloxacin - administration & dosage ciprofloxacin hydrochloride cospray drying Doxycycline - administration & dosage doxycycline hydrochloride DPI Drug Combinations dry powder inhaler General pharmacology Humans Lung - metabolism Medical sciences Microbial Sensitivity Tests Microscopy, Electron, Scanning Particle Size Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Powders Pseudomonas aeruginosa - drug effects Staphylococcus aureus - drug effects Streptococcus pyogenes - drug effects X-Ray Diffraction |
title | Cospray Dried Antibiotics for Dry Powder Lung Delivery |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A08%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cospray%20Dried%20Antibiotics%20for%20Dry%20Powder%20Lung%20Delivery&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Adi,%20Handoko&rft.date=2008-08&rft.volume=97&rft.issue=8&rft.spage=3356&rft.epage=3366&rft.pages=3356-3366&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.21239&rft_dat=%3Cproquest_cross%3E69358508%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69358508&rft_id=info:pmid/17990305&rfr_iscdi=true |